Vanguard Group’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,265,802
| Closed | -$29.8M | – | 4408 |
|
|
2025
Q2 | $29.8M | Sell |
3,265,802
-1,811,486
| -36% | -$13.3M | ﹤0.01% | 2368 |
|
|
2025
Q1 | $40.4M | Buy |
5,077,288
+239,119
| +5% | +$1.75M | ﹤0.01% | 2178 |
|
|
2024
Q4 | $26.3M | Sell |
4,838,169
-922,280
| -16% | -$5.64M | ﹤0.01% | 2455 |
|
|
2024
Q3 | $41.6M | Sell |
5,760,449
-655,872
| -10% | -$6M | ﹤0.01% | 2258 |
|
|
2024
Q2 | $69.7M | Buy |
6,416,321
+664,948
| +12% | +$8.52M | ﹤0.01% | 2013 |
|
|
2024
Q1 | $108M | Buy |
5,751,373
+432,013
| +8% | +$9.96M | ﹤0.01% | 1818 |
|
|
2023
Q4 | $115M | Buy |
5,319,360
+111,358
| +2% | +$2.21M | ﹤0.01% | 1790 |
|
|
2023
Q3 | $107M | Buy |
5,208,002
+175,565
| +3% | +$5.07M | ﹤0.01% | 1773 |
|
|
2023
Q2 | $237M | Buy |
5,032,437
+52,666
| +1% | +$2.62M | 0.01% | 1382 |
|
|
2023
Q1 | $209M | Buy |
4,979,771
+94,219
| +2% | +$4.05M | 0.01% | 1429 |
|
|
2022
Q4 | $186M | Buy |
4,885,552
+97,687
| +2% | +$3.73M | 0.01% | 1471 |
|
|
2022
Q3 | $187M | Buy |
4,787,865
+45,026
| +0.9% | +$1.74M | 0.01% | 1421 |
|
|
2022
Q2 | $153M | Buy |
4,742,839
+117,836
| +3% | +$3.95M | ﹤0.01% | 1581 |
|
|
2022
Q1 | $153M | Buy |
4,625,003
+46,762
| +1% | +$1.76M | ﹤0.01% | 1718 |
|
|
2021
Q4 | $195M | Sell |
4,578,241
-253,028
| -5% | -$10.6M | ﹤0.01% | 1627 |
|
|
2021
Q3 | $214M | Buy |
4,831,269
+6,459
| +0.1% | +$296K | 0.01% | 1563 |
|
|
2021
Q2 | $274M | Buy |
4,824,810
+66,772
| +1% | +$4.72M | 0.01% | 1425 |
|
|
2021
Q1 | $356M | Buy |
4,758,038
+158,923
| +3% | +$13M | 0.01% | 1187 |
|
|
2020
Q4 | $398M | Buy |
4,599,115
+78,675
| +2% | +$5.8M | 0.01% | 1011 |
|
|
2020
Q3 | $276M | Sell |
4,520,440
-212,592
| -4% | -$10.8M | 0.01% | 1058 |
|
|
2020
Q2 | $197M | Sell |
4,733,032
-101,820
| -2% | -$3.7M | 0.01% | 1279 |
|
|
2020
Q1 | $139M | Buy |
4,834,852
+144,070
| +3% | +$8.34M | 0.01% | 1337 |
|
|
2019
Q4 | $339M | Buy |
4,690,782
+44,521
| +1% | +$5.48M | 0.01% | 1055 |
|
|
2019
Q3 | $652M | Buy |
4,646,261
+39,831
| +0.9% | +$6.66M | 0.02% | 673 |
|
|
2019
Q2 | $843M | Buy |
4,606,430
+40,731
| +0.9% | +$6.95M | 0.03% | 575 |
|
|
2019
Q1 | $726M | Buy |
4,565,699
+543,229
| +14% | +$78.7M | 0.03% | 607 |
|
|
2018
Q4 | $385M | Sell |
4,022,470
-63,342
| -2% | -$7.25M | 0.02% | 835 |
|
|
2018
Q3 | $577M | Buy |
4,085,812
+262,990
| +7% | +$40.6M | 0.02% | 718 |
|
|
2018
Q2 | $598M | Buy |
3,822,822
+60,038
| +2% | +$9.43M | 0.03% | 682 |
|
|
2018
Q1 | $606M | Buy |
3,762,784
+410,339
| +12% | +$69.7M | 0.03% | 654 |
|
|
2017
Q4 | $552M | Buy |
3,352,445
+522,193
| +18% | +$50.6M | 0.02% | 708 |
|
|
2017
Q3 | $176M | Buy |
2,830,252
+80,298
| +3% | +$6.31M | 0.01% | 1360 |
|
|
2017
Q2 | $219M | Buy |
2,749,954
+58,679
| +2% | +$4.24M | 0.01% | 1171 |
|
|
2017
Q1 | $191M | Buy |
2,691,275
+261,759
| +11% | +$15.3M | 0.01% | 1246 |
|
|
2016
Q4 | $124M | Buy |
2,429,516
+132,749
| +6% | +$6.26M | 0.01% | 1493 |
|
|
2016
Q3 | $106M | Buy |
2,296,767
+554,206
| +32% | +$22.6M | 0.01% | 1523 |
|
|
2016
Q2 | $52.5M | Buy |
1,742,561
+121,186
| +7% | +$4.04M | ﹤0.01% | 1880 |
|
|
2016
Q1 | $52M | Buy |
1,621,375
+289,398
| +22% | +$10.2M | ﹤0.01% | 1847 |
|
|
2015
Q4 | $77.7M | Buy |
1,331,977
+199,316
| +18% | +$9.87M | 0.01% | 1641 |
|
|
2015
Q3 | $47.9M | Buy |
1,132,661
+272,472
| +32% | +$16.8M | ﹤0.01% | 1892 |
|
|
2015
Q2 | $62.8M | Buy |
860,189
+237,246
| +38% | +$15.3M | ﹤0.01% | 1816 |
|
|
2015
Q1 | $31.3M | Buy |
622,943
+400,198
| +180% | +$17.2M | ﹤0.01% | 2139 |
|
|
2014
Q4 | $8.15M | Buy |
222,745
+190,220
| +585% | +$7.09M | ﹤0.01% | 2638 |
|
|
2014
Q3 | $1.02M | Buy |
+32,525
| New | +$942K | ﹤0.01% | 3499 |
|
Other funds holding SAGE
IA
HNB